Prednisolone and Mycobacterium indicus pranii in tuberculous pericarditis

New England Journal of Medicine

Volumn 371, Issue 12, 2014, Pages 1121-1130

  Mayosi, B M ^a   Ntsekhe, M ^a   Bosch, J ^h   Pandie, S ^a   Jung, H ^h   Gumedze, F ^b   Pogue, J ^h   Thabane, L ^h   Smieja, M ^h   Francis, V ^a   Joldersma, L ^h   Thomas, K M ^c   Thomas, B ^c   Awotedu, A A ^c   Magula, N P ^d   Naidoo, D P ^d   Damasceno, A ⁱ   Banda, A C ^j   Brown, B ^c   Manga, P ^e   Kirenga, B ^k   Mondo, C ^k   Mntla, P ^f   Tsitsi, J M ^g   Peters, F ^g   Essop, M R ^g   Russell, J B W ^l   Hakim, J ^m   Matenga, J ^m   Barasa, A F ⁿ   Sani, M U ^o   Olunuga, T ^p   Ogah, O ^p   Ansa, V ^q   Aje, A ^r   Danbauchi, S ^s   Ojji, D ^t   Yusuf, S ^h   more..

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

^c WALTER SISULU UNIVERSITY   (South Africa)

^d UNIVERSITY OF KWAZULU NATAL   (South Africa)

^e UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^f UNIVERSITY OF LIMPOPO   (South Africa)

^g UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^h MCMASTER UNIVERSITY   (Canada)

ⁱ MAPUTO CENTRAL HOSPITAL   (Mozambique)

^j Malawi Military Health Services   (Malawi)

^k MULAGO HOSPITAL   (Uganda)

^l Ministry of Health and Sanitation   (Sierra Leone)

^m Andrew Fleming Hospital   (Zimbabwe)

ⁿ Moi Hospital   (Kenya)

^o AMINU KANO TEACHING HOSPITAL   (Nigeria)

^p FEDERAL MEDICAL CENTER   (Nigeria)

^q UNIVERSITY OF CALABAR   (Nigeria)

^r UNIVERSITY OF IBADAN   (Nigeria)

^s Ahmadu Bello Teaching Hospital   (Nigeria)

^t Abuja Teaching Hospital   (Nigeria)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; GLUCOCORTICOID; PLACEBO; PREDNISOLONE; TUBERCULOSTATIC AGENT;

ADULT; ARTICLE; CANCER INCIDENCE; CONSTRICTIVE PERICARDITIS; CONTROLLED STUDY; DEATH; DISEASE ASSOCIATION; FACTORIAL DESIGN; FEMALE; HAZARD RATIO; HEART TAMPONADE; HOSPITALIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; MYCOBACTERIUM INDICUS PRANII; PERICARDIOCENTESIS; RANDOMIZED CONTROLLED TRIAL; TUBERCULOUS PERICARDITIS; CONTROLLED CLINICAL TRIAL; IMMUNOLOGY; IMMUNOTHERAPY; KAPLAN MEIER METHOD; MULTICENTER STUDY; MULTIMODALITY CANCER THERAPY; MYCOBACTERIUM; TREATMENT FAILURE;

ADULT; CARDIAC TAMPONADE; COMBINED MODALITY THERAPY; FEMALE; GLUCOCORTICOIDS; HIV INFECTIONS; HUMANS; IMMUNOTHERAPY; KAPLAN-MEIER ESTIMATE; MALE; MYCOBACTERIUM; PERICARDIOCENTESIS; PERICARDITIS, CONSTRICTIVE; PERICARDITIS, TUBERCULOUS; PREDNISOLONE; TREATMENT FAILURE;

EID: 84907406784     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa1407380     Document Type: Article

References (37)

1. Mayosi BM, Wiysonge CS, Ntsekhe M, et al. Clinical characteristics and initial management of patients with tuberculous pericarditis in the HIV era: the Investigation of the Management of Pericarditis in Africa (IMPI Africa) registry. BMC Infect Dis 2006;6:2.
2. Mutyaba A, Balkaran S, Cloete R, et al. Constrictive pericarditis requiring pericardiectomy at Groote Schuur Hospital in Cape Town, South Africa: causes and peri-operative outcomes in the HIV era (1990-2012). J Thorac Cardiovasc Surg (in press).
3. Cherian G. Diagnosis of tuberculous aetiology in pericardial effusions. Postgrad Med J 2004;80:262-6.
4. Mayosi BM, Burgess LJ, Doubell AF. Tuberculous pericarditis. Circulation 2005;112:3608-16.
5. Mayosi BM, Wiysonge CS, Ntsekhe M, et al. Mortality in patients treated for tuberculous pericarditis in sub-Saharan Africa. S Afr Med J 2008;98:36-40.
6. Evans DJ. The use of adjunctive corticosteroids in the treatment of pericardial, pleural and meningeal tuberculosis: do they improve outcome? Respir Med 2008; 102:793-800.
7. Mayosi BM, Ntsekhe M, Volmink JA, Commerford PJ. Interventions for treating tuberculous pericarditis. Cochrane Database Syst Rev 2002;4:CD000526.
8. Ntsekhe M, Wiysonge C, Volmink JA, Commerford PJ, Mayosi BM. Adjuvant corticosteroids for tuberculous pericarditis: promising, but not proven. QJM 2003; 96:593-9.
9. Maisch B, Seferović PM, Ristić AD, et al. Guidelines on the diagnosis and management of pericardial diseases executive summary: the Task Force on the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology. Eur Heart J 2004;25:587-610.
10. Critchley JA, Young F, Orton L, Garner P. Corticosteroids for prevention of mortality in people with tuberculosis: a systematic review and meta-analysis. Lancet Infect Dis 2013;13:223-37.
11. Elliott AM, Halwiindi B, Bagshawe A, et al. Use of prednisolone in the treatment of HIV-positive tuberculosis patients. Q J Med 1992;85:855-60.
12. Elliott AM, Luzze H, Quigley MA, et al. A randomized, double-blind, placebocontrolled trial of the use of prednisolone as an adjunct to treatment in HIV-1-associated pleural tuberculosis. J Infect Dis 2004;190:869-78.
13. Treatment of tuberculosis: guidelines. Geneva: World Health Organization, 2010.
14. Treatment of tuberculosis. MMWR Recomm Rep 2003;52(RR-11):1-77.
15. Saini V, Raghuvanshi S, Talwar GP, et al. Polyphasic taxonomic analysis establishes Mycobacterium indicus pranii as a distinct species. PLoS One 2009;4(7): e6263.
16. Mathur ML. Potential utility of Mycobacterium w vaccine in control of tuberculosis. Curr Respir Med Rev 2006;2:183-8.
17. Gupta A, Ahmad FJ, Ahmad F, et al. Efficacy of Mycobacterium indicus pranii immunotherapy as an adjunct to chemotherapy for tuberculosis and underlying immune responses in the lung. PLoS One 2012;7(7):e39215.
18. Talwar GP. An immunotherapeutic vaccine for multibacillary leprosy. Int Rev Immunol 1999;18:229-49.
19. Gupta S, Malhotra AK, Verma KK, Sharma VK. Intralesional immunotherapy with killed Mycobacterium w vaccine for the treatment of ano-genital warts: an open label pilot study. J Eur Acad Dermatol Venereol 2008;22:1089-93.
20. Nath I. A vaccine for leprosy. Nat Med 1998;4:548-50.
21. Kharkar R. Immune recovery in HIV with Mycobacterium w. J Indian Med Assoc 2002;100:578-9.
22. Sharma P, Mukherjee R, Talwar GP, et al. Immunoprophylactic effects of the anti-leprosy Mw vaccine in household contacts of leprosy patients: clinical field trials with a follow up of 8-10 years. Lepr Rev 2005;76:127-43.
23. Mayosi BM, Ntsekhe M, Bosch J, et al. Rationale and design of the Investigation of the Management of Pericarditis (IMPI) trial: a 2 × 2 factorial randomized doubleblind multicenter trial of adjunctive prednisolone and Mycobacterium w immunotherapy in tuberculous pericarditis. Am Heart J 2013;165:109-15.
24. Reuter H, Burgess L, van Vuuren W, Doubell A. Diagnosing tuberculous pericarditis. QJM 2006;99:827-39.
25. Pandie S, Peter JG, Kerbelker ZS, et al. Diagnostic accuracy of quantitative PCR (Xpert MTB/RIF) for tuberculous pericarditis compared to adenosine deaminase and unstimulated interferon-γ in a high burden setting: a prospective study. BMC Med 2014;12:101.
26. Antiretroviral therapy for HIV infection in adults and adolescents: recommendations for a public health approach (2006 revision). Geneva: World Health Organization, 2006.
27. Antiretroviral therapy for HIV infection in adults and adolescents: recommendations for a public health approach: 2010 revision. Geneva: World Health Organization, 2010.
28. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. Geneva: World Health Organization, 2013.
29. Schrire V. Experience with pericarditis at Groote Schuur Hospital, Cape Town: an analysis of one hundred and sixty cases studied over a six-year period. S Afr Med J 1959;33:810-7.
30. Lepper MH, Spies HW. The present status of the treatment of tuberculosis of the central nervous system. Ann N Y Acad Sci 1963;106:106-23.
31. Strang JI, Kakaza HH, Gibson DG, Girling DJ, Nunn AJ, Fox W. Controlled trial of prednisolone as adjuvant in treatment of tuberculous constrictive pericarditis in Transkei. Lancet 1987;2:1418-22.
32. Strang JI, Kakaza HH, Gibson DG, et al. Controlled clinical trial of complete open surgical drainage and of prednisolone in treatment of tuberculous pericardial effusion in Transkei. Lancet 1988;2:759-64.
33. Hakim JG, Ternouth I, Mushangi E, Siziya S, Robertson V, Malin A. Double blind randomised placebo controlled trial of adjunctive prednisolone in the treatment of effusive tuberculous pericarditis in HIV seropositive patients. Heart 2000; 84:183-8.
34. Reuter H, Burgess LJ, Louw VJ, Doubell AF. Experience with adjunctive corticosteroids in managing tuberculous pericarditis. Cardiovasc J S Afr 2006;17: 233-8.
35. Strang JI. Rapid resolution of tuberculous pericardial effusions with high dose prednisone and anti-tuberculous drugs. J Infect 1994;28:251-4.
36. Zuhlke L, Mirabel M, Marijon E. Congenital heart disease and rheumatic heart disease in Africa: recent advances and current priorities. Heart 2013;99:1554-61.
37. Thwaites GE, Nguyen DB, Nguyen HD, et al. Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults. N Engl J Med 2004; 351:1741-51.